An Investigation of rhTPO With Different Frequencies in the Management of ITP
NCT02139501
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
48
Enrollment
OTHER
Sponsor class
Conditions
Immune Thrombocytopenia
Interventions
DRUG:
Recombinant Human Thrombopoietin (rhTPO)
Sponsor
Shandong University
Collaborators
[object Object]
[object Object]